Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer

医学 免疫疗法 内科学 肺癌 肿瘤科 放射治疗 癌症 胃肠病学 免疫学
作者
Yeona Cho,Sang Joon Park,Hwa Kyung Byun,Chang Geol Lee,Jaeho Cho,Min Hee Hong,Hye Ryun Kim,Byoung Chul Cho,Sinae Kim,Juyoung Park,Hong In Yoon
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:105 (5): 1065-1073 被引量:124
标识
DOI:10.1016/j.ijrobp.2019.08.047
摘要

Purpose The interest in combining radiation therapy (RT) with immunotherapy is increasing. We investigated the significance of lymphopenia in patients receiving immunotherapy for non-small cell lung cancer (NSCLC), and the factors associated with treatment-related lymphopenia, with particular emphasis on RT. Methods and Methods In this retrospective single institution study, 268 patients with advanced NSCLC received immunotherapy, of whom 146 received RT. Lymphopenia was defined as an absolute lymphocyte count <1000 cells/mm.3 Patients were divided into 2 groups depending on the presence of peri-immunotherapy lymphopenia at the start of immunotherapy or during immunotherapy. Results At median 6.4 months of follow-up, patients with peri-immunotherapy lymphopenia (n = 146; 54.5%) showed significantly poorer progression-free survival (PFS) (median PFS: 2.2 vs 5.9 months, P < .001) and overall survival (OS) (median OS: 5.7 vs 12.1 months, P < .001). On multivariate analysis, peri-immunotherapy lymphopenia remained a significant prognostic factor for both PFS and OS. RT significantly increased peri-immunotherapy lymphopenia with an odds ratio (OR) of 1.91 (P = .025). Factors associated with the development of RT-associated lymphopenia included multiple courses (OR, 3.78; P < .001), multiple irradiated sites (OR, 4.77; P = .018), and higher dose (≥50 Gy) (OR, 3.75; P = .004). Conversely, stereotactic body RT/radiosurgery reduced the risk (OR 0.21; P = .002). Conclusions Lymphopenia was indicative of poor prognosis in NSCLC patients receiving immunotherapy and was significantly associated with more intensive RT. Choosing appropriate RT regimens and techniques may be essential in reducing lymphopenia. Promising results are expected in the era of precision RT. The interest in combining radiation therapy (RT) with immunotherapy is increasing. We investigated the significance of lymphopenia in patients receiving immunotherapy for non-small cell lung cancer (NSCLC), and the factors associated with treatment-related lymphopenia, with particular emphasis on RT. In this retrospective single institution study, 268 patients with advanced NSCLC received immunotherapy, of whom 146 received RT. Lymphopenia was defined as an absolute lymphocyte count <1000 cells/mm.3 Patients were divided into 2 groups depending on the presence of peri-immunotherapy lymphopenia at the start of immunotherapy or during immunotherapy. At median 6.4 months of follow-up, patients with peri-immunotherapy lymphopenia (n = 146; 54.5%) showed significantly poorer progression-free survival (PFS) (median PFS: 2.2 vs 5.9 months, P < .001) and overall survival (OS) (median OS: 5.7 vs 12.1 months, P < .001). On multivariate analysis, peri-immunotherapy lymphopenia remained a significant prognostic factor for both PFS and OS. RT significantly increased peri-immunotherapy lymphopenia with an odds ratio (OR) of 1.91 (P = .025). Factors associated with the development of RT-associated lymphopenia included multiple courses (OR, 3.78; P < .001), multiple irradiated sites (OR, 4.77; P = .018), and higher dose (≥50 Gy) (OR, 3.75; P = .004). Conversely, stereotactic body RT/radiosurgery reduced the risk (OR 0.21; P = .002). Lymphopenia was indicative of poor prognosis in NSCLC patients receiving immunotherapy and was significantly associated with more intensive RT. Choosing appropriate RT regimens and techniques may be essential in reducing lymphopenia. Promising results are expected in the era of precision RT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Gilana完成签到,获得积分10
1秒前
xyh发布了新的文献求助10
1秒前
江璃完成签到,获得积分10
2秒前
TT发布了新的文献求助10
2秒前
美梦成真完成签到,获得积分10
3秒前
Gakay完成签到,获得积分10
3秒前
量子星尘发布了新的文献求助10
4秒前
szj完成签到,获得积分0
5秒前
旦皋完成签到,获得积分10
5秒前
赘婿应助花壳在逃野猪采纳,获得10
6秒前
卷卷完成签到,获得积分10
8秒前
JSY完成签到 ,获得积分20
8秒前
xyh完成签到,获得积分10
9秒前
小曾应助Florencia采纳,获得10
10秒前
神外王001完成签到 ,获得积分10
10秒前
15秒前
你是谁完成签到,获得积分10
16秒前
majf完成签到,获得积分10
17秒前
linhanwenzhou完成签到,获得积分10
17秒前
JSY关注了科研通微信公众号
17秒前
853225598完成签到,获得积分10
17秒前
798完成签到,获得积分10
18秒前
善学以致用应助董怼怼采纳,获得10
18秒前
妍儿完成签到,获得积分20
19秒前
隐形曼青应助高大的水壶采纳,获得10
19秒前
马哥二弟无敌完成签到 ,获得积分10
20秒前
21秒前
Florencia完成签到,获得积分10
21秒前
务实颜完成签到 ,获得积分10
21秒前
21秒前
amberzyc应助小远采纳,获得10
22秒前
22秒前
23秒前
23秒前
24秒前
24秒前
Rondab应助小猪采纳,获得30
24秒前
DLDL完成签到,获得积分10
24秒前
25秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038368
求助须知:如何正确求助?哪些是违规求助? 3576068
关于积分的说明 11374313
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029